Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.23 USD | +5.35% | +3.74% | -20.83% |
02:56pm | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
Apr. 15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
Financials (USD)
Sales 2024 * | 50.25M | Sales 2025 * | 52.42M | Capitalization | 2.22B |
---|---|---|---|---|---|
Net income 2024 * | -512M | Net income 2025 * | -523M | EV / Sales 2024 * | 29.9 x |
Net cash position 2024 * | 717M | Net cash position 2025 * | 991M | EV / Sales 2025 * | 23.4 x |
P/E ratio 2024 * |
-4.16
x | P/E ratio 2025 * |
-4.34
x | Employees | 526 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.91% |
Latest transcript on Intellia Therapeutics, Inc.
1 day | +5.15% | ||
1 week | +3.74% | ||
Current month | +12.80% | ||
1 month | -7.44% | ||
3 months | -14.49% | ||
6 months | -3.29% | ||
Current year | -20.83% |
Managers | Title | Age | Since |
---|---|---|---|
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Glenn Goddard
DFI | Director of Finance/CFO | 53 | 18-10-28 |
Eliana Clark
CTO | Chief Tech/Sci/R&D Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Cohen
BRD | Director/Board Member | 67 | 19-01-23 |
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Frank Verwiel
CHM | Chairman | 62 | 17-07-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.15% | 2 M€ | -25.75% | ||
4.87% | 0 M€ | 0.00% | - | |
4.17% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 24.14 | +4.96% | 532 047 |
24-05-08 | 23 | -3.69% | 1,375,019 |
24-05-07 | 23.88 | +0.67% | 1,096,319 |
24-05-06 | 23.72 | +0.51% | 1,495,293 |
24-05-03 | 23.6 | +1.42% | 1,294,988 |
Delayed Quote Nasdaq, May 09, 2024 at 11:33 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.83% | 2.22B | |
+24.31% | 46.71B | |
+48.83% | 41.8B | |
-1.21% | 41.52B | |
-3.42% | 29.55B | |
+10.84% | 25.78B | |
-21.25% | 19.26B | |
+0.53% | 12.14B | |
-3.35% | 12.08B | |
+26.84% | 11.98B |
- Stock Market
- Equities
- NTLA Stock